Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis
NCT02124928 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2015-09-21
Summary
The aim of this study is to investigate the association of sonographic and histological features of the plaque among each other and with biomarkers of cardiovascular risk. The predictive value of these factors concerning the long-term clinical outcome after carotid endarterectomy will also be assessed. This may help to improve the identification of patients with carotid artery stenosis who will benefit most from carotid endarterectomy. The investigators major hypothesis is that the morphology of carotid plaques is associated with objectifiable sonographic parameters, in particular with the greyscale median. Second, the investigators hypothesize that sonographic and histological plaque morphology are associated with certain biomarkers of cardiovascular risk. Identification of 'vulnerable plaques' on the basis of a peripheral blood draw and a sonographic investigation may enable the treating physician to focus resources on patients who will benefit most form therapeutic interventions for primary prevention of ischemic stroke.
Conditions
- Atherosclerosis
- Carotid Artery Disease
Interventions
- PROCEDURE
-
Carotid endarterectomy
Carotid endarterectomy is a surgery used to reduce the risk of stroke, by correcting stenosis in the carotid artery. Endarterectomy is the removal of material on the inside (end-) of an artery.An incision is made on the midline side of the Sternocleidomastoid muscle. The incision is between 5 and 10 cm in length. Then the patients get 5000 IU heparin by the anesthesia. The internal, common and external carotid arteries are carefully identified, controlled with vessel loops, and clamped. The lumen of the internal carotid artery is opened, and the atheromatous plaque removed. The artery is closed using suture. The procedure is performed under local anesthesia. Local anesthesia, opposite to general, allows for direct monitoring of neurological status by intra-operative verbal contact and testing of grip strength.
Sponsors & Collaborators
-
Wilhelminenspital Vienna
collaborator OTHER -
Prim PD Dr Afshin Assadian
lead OTHER
Principal Investigators
-
Afshin Assadian, Prim PD Dr · Georg Hagmüller Institute for Vascular Research Wilheminenspital Vienna, Austria
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- Austria
Study Locations
More Related Trials
-
Arachidonic Acid Metabolism in Carotid Stenosis Plaque in Diabetic Patients
NCT03202823 ·Status: COMPLETED
-
Atherosclerosis in the Coronary and Carotid Arteries
NCT00080587 ·Status: COMPLETED
-
Efficacy and Safety of Pactimibe in Patients With Atherosclerosis
NCT00185146 ·Status: COMPLETED ·Phase: PHASE2
-
Carotid Plaque Screening Trial in Smokers
NCT00548665 ·Status: COMPLETED ·Phase: PHASE4
-
Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients
NCT05549336 ·Status: UNKNOWN
-
Study Effect of VIA-2291 on Atherosclerotic Vascular Inflammation in Patients Undergoing Elective Carotid Endarterectomy
NCT00352417 ·Status: COMPLETED ·Phase: PHASE2
-
Bacteria in Atherosclerotic Plaques and Adverse Events
NCT06935279 ·Status: COMPLETED
-
Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease
NCT02393612 ·Status: COMPLETED ·Phase: PHASE3
-
Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
NCT02114697 ·Status: TERMINATED ·Phase: PHASE4
-
Biomarkers and Unstable Carotid Plaque
NCT06887894 ·Status: RECRUITING
-
Revacept in Symptomatic Carotid Stenosis
NCT01645306 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
NCT00636766 ·Status: COMPLETED ·Phase: NA
-
Neuroinflammation in Asymptomatic Carotid Artery Disease - Imaging Substudy
NCT05238961 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy
NCT04539223 ·Status: UNKNOWN ·Phase: PHASE4
-
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
NCT01178320 ·Status: COMPLETED
-
Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.
NCT00798005 ·Status: COMPLETED ·Phase: PHASE2
-
Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI)
NCT00388843 ·Status: WITHDRAWN
-
Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
NCT01604213 ·Status: COMPLETED ·Phase: PHASE4
-
Correlation of Artherosclerotic Plaque Volume and Intima Media Thickness With Soluble P-selectin
NCT01895725 ·Status: ACTIVE_NOT_RECRUITING
-
Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis
NCT01321476 ·Status: WITHDRAWN
-
Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2)
NCT02369848 ·Status: COMPLETED ·Phase: NA
-
Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM
NCT02266030 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza A VIRus and Destabilization of Atherosclerotic Carotid Plaques
NCT06217471 ·Status: COMPLETED
-
T-Mem GEne in Atherosclerosis
NCT06230406 ·Status: RECRUITING
-
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
NCT06204237 ·Status: RECRUITING ·Phase: EARLY_PHASE1